Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
– Nufarm to pay up to USD $5 million in consideration for the license
-The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm
Related news for (YTEN)
- Yield10 Bioscience Announces Second Quarter 2024 Financial Results
- Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
- Yield10 Bioscience Announces First Quarter 2024 Financial Results